Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Kosan BioSciences -- KOSN -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (523)	4/7/2005 12:08:50 PM
From: zeta1961	Read Replies (1) \| Respond to of 933

silent faithful ones who would rather suffer than make a case for their stocks..... KOSN is up 25% today, Yeah!..I just posted on the valuation thread..KOSN had been in my basket of ASCO plays I set up during the last 10ish days but I didn't buy..dang! OTOH..It's really hard, imho, for people to 'stand by their stocks' in this environment of a spate of bad news coming out on almost a weekly basis..Tysabri stung too many/the cancer small ones have not graced us with much to munch on..I think it takes time to recover..you know that..a novice advising a veteran..ridiculous endeavour for the novice.. Zeta..

To: scaram(o)uche who wrote (523)	4/7/2005 12:16:36 PM
From: zeta1961	Read Replies (1) \| Respond to of 933

Message 21162964 Doing my best with this rejected and maligned pup! PS..Rick..I just got to the munch thread..read about your kids' recent success.. Congrats to you(big ones)..doing this work is peanuts compared to what you're doing at home.. Zeta

To: scaram(o)uche who wrote (523)	4/7/2005 3:34:09 PM
From: mopgcw	Respond to of 933

Just keep turning over rocks to find more undervalued stuff to make money. Hoping the market gives us more stupid opportunities where stuff trades close to cash with pipeline potential. Sometimes it is brutal and takes sheer bravery and stupidity to stand in front of the train. I sense folks here are bit shell shocked lately at all the bad news -- merck, chiron, biib, now pfizer. but the calls are being made, perhaps just a bit quieter than before.

To: scaram(o)uche who wrote (523)	4/15/2005 4:40:25 PM
From: scaram(o)uche	Respond to of 933

ASCO...... Sunday, 5/15/2005, 8:00 - 12:00pm Phase 1 and pharmacokinetic (PK) study of weekly KOS-862 (Epothilone D) combined with gemcitabine (GEM) in patients (Pts) with advanced solid tumors Presenter: John L Marshall, MD Developmental Therapeutics: Cytotoxic Chemotherapy Sunday, 5/15/2005, 8:00 - 12:00pm Phase 1 trial of KOS-862 (epothilone D) in combination with carboplatin (C) in patients with solid tumors Presenter: J. Paul Monk, MD Developmental Therapeutics: Cytotoxic Chemotherapy Tuesday, 5/17/2005, 8:00 - 12:00pm A phase II study of KOS-862 (epothilone D) as second-line therapy in non-small cell lung cancer Presenter: Lorrin Yee Lung Cancer